nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—GLUL—mammary gland—sarcoma	0.00821	0.0952	CbGeAlD
Ceftriaxone—GLUL—myometrium—sarcoma	0.00582	0.0676	CbGeAlD
Ceftriaxone—GLUL—embryo—sarcoma	0.0056	0.065	CbGeAlD
Ceftriaxone—ALB—mammary gland—sarcoma	0.00508	0.0589	CbGeAlD
Ceftriaxone—GLUL—hematopoietic system—sarcoma	0.005	0.058	CbGeAlD
Ceftriaxone—GLUL—connective tissue—sarcoma	0.00482	0.0558	CbGeAlD
Ceftriaxone—GLUL—smooth muscle tissue—sarcoma	0.0044	0.0511	CbGeAlD
Ceftriaxone—GLUL—skin of body—sarcoma	0.00435	0.0504	CbGeAlD
Ceftriaxone—SLC15A2—mammary gland—sarcoma	0.00424	0.0492	CbGeAlD
Ceftriaxone—GLUL—uterus—sarcoma	0.00378	0.0438	CbGeAlD
Ceftriaxone—GLUL—lymphoid tissue—sarcoma	0.00352	0.0408	CbGeAlD
Ceftriaxone—GLUL—tendon—sarcoma	0.00331	0.0384	CbGeAlD
Ceftriaxone—GLUL—bone marrow—sarcoma	0.00321	0.0372	CbGeAlD
Ceftriaxone—Anaemia—Dactinomycin—sarcoma	0.003	0.00329	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00298	0.00327	CcSEcCtD
Ceftriaxone—SLC22A8—hematopoietic system—sarcoma	0.00297	0.0345	CbGeAlD
Ceftriaxone—Renal failure—Etoposide—sarcoma	0.00296	0.00324	CcSEcCtD
Ceftriaxone—Stomatitis—Etoposide—sarcoma	0.00293	0.00321	CcSEcCtD
Ceftriaxone—Jaundice—Etoposide—sarcoma	0.00293	0.00321	CcSEcCtD
Ceftriaxone—Leukopenia—Thiotepa—sarcoma	0.00293	0.00321	CcSEcCtD
Ceftriaxone—Malaise—Dactinomycin—sarcoma	0.00293	0.00321	CcSEcCtD
Ceftriaxone—Chills—Mitoxantrone—sarcoma	0.00292	0.00319	CcSEcCtD
Ceftriaxone—Leukopenia—Dactinomycin—sarcoma	0.00291	0.00318	CcSEcCtD
Ceftriaxone—Colitis—Epirubicin—sarcoma	0.0029	0.00317	CcSEcCtD
Ceftriaxone—Candida infection—Epirubicin—sarcoma	0.00288	0.00315	CcSEcCtD
Ceftriaxone—Vaginal infection—Epirubicin—sarcoma	0.00285	0.00312	CcSEcCtD
Ceftriaxone—Convulsion—Thiotepa—sarcoma	0.00284	0.00311	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Epirubicin—sarcoma	0.00283	0.0031	CcSEcCtD
Ceftriaxone—Agranulocytosis—Etoposide—sarcoma	0.00281	0.00307	CcSEcCtD
Ceftriaxone—Vaginal inflammation—Doxorubicin—sarcoma	0.00279	0.00305	CcSEcCtD
Ceftriaxone—Dysgeusia—Mitoxantrone—sarcoma	0.00277	0.00303	CcSEcCtD
Ceftriaxone—GLUL—testis—sarcoma	0.00274	0.0318	CbGeAlD
Ceftriaxone—Discomfort—Dactinomycin—sarcoma	0.00273	0.00299	CcSEcCtD
Ceftriaxone—SLC22A11—liver—sarcoma	0.00273	0.0317	CbGeAlD
Ceftriaxone—SLC15A2—seminal vesicle—sarcoma	0.00272	0.0315	CbGeAlD
Ceftriaxone—Anaemia—Vincristine—sarcoma	0.00268	0.00294	CcSEcCtD
Ceftriaxone—Colitis—Doxorubicin—sarcoma	0.00268	0.00293	CcSEcCtD
Ceftriaxone—Agitation—Vincristine—sarcoma	0.00267	0.00292	CcSEcCtD
Ceftriaxone—Candida infection—Doxorubicin—sarcoma	0.00266	0.00292	CcSEcCtD
Ceftriaxone—Infection—Thiotepa—sarcoma	0.00266	0.00291	CcSEcCtD
Ceftriaxone—Oedema—Dactinomycin—sarcoma	0.00265	0.0029	CcSEcCtD
Ceftriaxone—Hypertonia—Epirubicin—sarcoma	0.00264	0.00289	CcSEcCtD
Ceftriaxone—Infection—Dactinomycin—sarcoma	0.00264	0.00288	CcSEcCtD
Ceftriaxone—Vaginal infection—Doxorubicin—sarcoma	0.00264	0.00288	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Mitoxantrone—sarcoma	0.00262	0.00287	CcSEcCtD
Ceftriaxone—Aplastic anaemia—Doxorubicin—sarcoma	0.00262	0.00287	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Thiotepa—sarcoma	0.00262	0.00286	CcSEcCtD
Ceftriaxone—Anaemia—Mitoxantrone—sarcoma	0.00261	0.00286	CcSEcCtD
Ceftriaxone—Leukopenia—Vincristine—sarcoma	0.0026	0.00284	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Dactinomycin—sarcoma	0.0026	0.00284	CcSEcCtD
Ceftriaxone—GLUL—liver—sarcoma	0.00259	0.0301	CbGeAlD
Ceftriaxone—Erythema multiforme—Etoposide—sarcoma	0.00256	0.0028	CcSEcCtD
Ceftriaxone—Malaise—Mitoxantrone—sarcoma	0.00255	0.00279	CcSEcCtD
Ceftriaxone—Phlebitis—Epirubicin—sarcoma	0.00254	0.00278	CcSEcCtD
Ceftriaxone—Leukopenia—Mitoxantrone—sarcoma	0.00253	0.00277	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Epirubicin—sarcoma	0.00253	0.00277	CcSEcCtD
Ceftriaxone—Convulsion—Vincristine—sarcoma	0.00252	0.00275	CcSEcCtD
Ceftriaxone—Flushing—Etoposide—sarcoma	0.00251	0.00274	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Epirubicin—sarcoma	0.00251	0.00274	CcSEcCtD
Ceftriaxone—Convulsion—Mitoxantrone—sarcoma	0.00245	0.00268	CcSEcCtD
Ceftriaxone—Hypertonia—Doxorubicin—sarcoma	0.00245	0.00268	CcSEcCtD
Ceftriaxone—Chills—Etoposide—sarcoma	0.00242	0.00265	CcSEcCtD
Ceftriaxone—Paraesthesia—Thiotepa—sarcoma	0.0024	0.00263	CcSEcCtD
Ceftriaxone—Discomfort—Mitoxantrone—sarcoma	0.00238	0.0026	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Vincristine—sarcoma	0.00237	0.00259	CcSEcCtD
Ceftriaxone—Oedema—Vincristine—sarcoma	0.00237	0.00259	CcSEcCtD
Ceftriaxone—Infection—Vincristine—sarcoma	0.00235	0.00258	CcSEcCtD
Ceftriaxone—Dyspepsia—Thiotepa—sarcoma	0.00235	0.00257	CcSEcCtD
Ceftriaxone—Phlebitis—Doxorubicin—sarcoma	0.00235	0.00257	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Doxorubicin—sarcoma	0.00234	0.00256	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Epirubicin—sarcoma	0.00232	0.00254	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Vincristine—sarcoma	0.00232	0.00254	CcSEcCtD
Ceftriaxone—Hepatic function abnormal—Doxorubicin—sarcoma	0.00232	0.00254	CcSEcCtD
Ceftriaxone—Oedema—Mitoxantrone—sarcoma	0.00231	0.00253	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Mitoxantrone—sarcoma	0.00231	0.00253	CcSEcCtD
Ceftriaxone—Dysgeusia—Etoposide—sarcoma	0.0023	0.00252	CcSEcCtD
Ceftriaxone—Renal impairment—Epirubicin—sarcoma	0.0023	0.00252	CcSEcCtD
Ceftriaxone—Infection—Mitoxantrone—sarcoma	0.00229	0.00251	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Vincristine—sarcoma	0.00229	0.00251	CcSEcCtD
Ceftriaxone—Pain—Thiotepa—sarcoma	0.00229	0.0025	CcSEcCtD
Ceftriaxone—Pain—Dactinomycin—sarcoma	0.00227	0.00248	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Epirubicin—sarcoma	0.00226	0.00248	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Mitoxantrone—sarcoma	0.00226	0.00247	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Mitoxantrone—sarcoma	0.00223	0.00244	CcSEcCtD
Ceftriaxone—Feeling abnormal—Thiotepa—sarcoma	0.0022	0.00241	CcSEcCtD
Ceftriaxone—Feeling abnormal—Dactinomycin—sarcoma	0.00219	0.00239	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Thiotepa—sarcoma	0.00219	0.00239	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Etoposide—sarcoma	0.00218	0.00239	CcSEcCtD
Ceftriaxone—Anaemia—Etoposide—sarcoma	0.00217	0.00238	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Dactinomycin—sarcoma	0.00217	0.00237	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00215	0.00235	CcSEcCtD
Ceftriaxone—SLC15A1—liver—sarcoma	0.00214	0.0248	CbGeAlD
Ceftriaxone—Renal impairment—Doxorubicin—sarcoma	0.00213	0.00233	CcSEcCtD
Ceftriaxone—Paraesthesia—Vincristine—sarcoma	0.00213	0.00233	CcSEcCtD
Ceftriaxone—Urticaria—Thiotepa—sarcoma	0.00212	0.00232	CcSEcCtD
Ceftriaxone—Malaise—Etoposide—sarcoma	0.00212	0.00232	CcSEcCtD
Ceftriaxone—Abdominal pain—Thiotepa—sarcoma	0.00211	0.00231	CcSEcCtD
Ceftriaxone—Body temperature increased—Thiotepa—sarcoma	0.00211	0.00231	CcSEcCtD
Ceftriaxone—Leukopenia—Etoposide—sarcoma	0.00211	0.0023	CcSEcCtD
Ceftriaxone—Abdominal pain—Dactinomycin—sarcoma	0.0021	0.0023	CcSEcCtD
Ceftriaxone—Body temperature increased—Dactinomycin—sarcoma	0.0021	0.0023	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00209	0.00229	CcSEcCtD
Ceftriaxone—Paraesthesia—Mitoxantrone—sarcoma	0.00207	0.00227	CcSEcCtD
Ceftriaxone—Ataxia—Epirubicin—sarcoma	0.00206	0.00225	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Epirubicin—sarcoma	0.00205	0.00225	CcSEcCtD
Ceftriaxone—Convulsion—Etoposide—sarcoma	0.00204	0.00223	CcSEcCtD
Ceftriaxone—Dyspepsia—Mitoxantrone—sarcoma	0.00203	0.00222	CcSEcCtD
Ceftriaxone—Pain—Vincristine—sarcoma	0.00203	0.00222	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Epirubicin—sarcoma	0.002	0.00219	CcSEcCtD
Ceftriaxone—GLUL—lymph node—sarcoma	0.00199	0.023	CbGeAlD
Ceftriaxone—Discomfort—Etoposide—sarcoma	0.00198	0.00217	CcSEcCtD
Ceftriaxone—Pain—Mitoxantrone—sarcoma	0.00197	0.00216	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00197	0.00216	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00197	0.00216	CcSEcCtD
Ceftriaxone—Hypersensitivity—Thiotepa—sarcoma	0.00197	0.00216	CcSEcCtD
Ceftriaxone—Hypersensitivity—Dactinomycin—sarcoma	0.00195	0.00214	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Vincristine—sarcoma	0.00194	0.00212	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Etoposide—sarcoma	0.00192	0.0021	CcSEcCtD
Ceftriaxone—Infection—Etoposide—sarcoma	0.00191	0.00209	CcSEcCtD
Ceftriaxone—Ataxia—Doxorubicin—sarcoma	0.00191	0.00208	CcSEcCtD
Ceftriaxone—Feeling abnormal—Mitoxantrone—sarcoma	0.0019	0.00208	CcSEcCtD
Ceftriaxone—Blood creatinine increased—Doxorubicin—sarcoma	0.0019	0.00208	CcSEcCtD
Ceftriaxone—Pruritus—Thiotepa—sarcoma	0.00189	0.00207	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00189	0.00207	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Etoposide—sarcoma	0.00188	0.00206	CcSEcCtD
Ceftriaxone—Eosinophilia—Epirubicin—sarcoma	0.00187	0.00205	CcSEcCtD
Ceftriaxone—Abdominal pain—Vincristine—sarcoma	0.00187	0.00205	CcSEcCtD
Ceftriaxone—Body temperature increased—Vincristine—sarcoma	0.00187	0.00205	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Etoposide—sarcoma	0.00186	0.00203	CcSEcCtD
Ceftriaxone—Pancreatitis—Epirubicin—sarcoma	0.00186	0.00203	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Doxorubicin—sarcoma	0.00185	0.00203	CcSEcCtD
Ceftriaxone—Urticaria—Mitoxantrone—sarcoma	0.00183	0.00201	CcSEcCtD
Ceftriaxone—Diarrhoea—Thiotepa—sarcoma	0.00183	0.002	CcSEcCtD
Ceftriaxone—Body temperature increased—Mitoxantrone—sarcoma	0.00182	0.002	CcSEcCtD
Ceftriaxone—Abdominal pain—Mitoxantrone—sarcoma	0.00182	0.002	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00182	0.002	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.00182	0.002	CcSEcCtD
Ceftriaxone—Diarrhoea—Dactinomycin—sarcoma	0.00182	0.00199	CcSEcCtD
Ceftriaxone—Neutropenia—Epirubicin—sarcoma	0.00177	0.00194	CcSEcCtD
Ceftriaxone—Dizziness—Thiotepa—sarcoma	0.00177	0.00193	CcSEcCtD
Ceftriaxone—Hypersensitivity—Vincristine—sarcoma	0.00175	0.00191	CcSEcCtD
Ceftriaxone—Eosinophilia—Doxorubicin—sarcoma	0.00173	0.0019	CcSEcCtD
Ceftriaxone—Paraesthesia—Etoposide—sarcoma	0.00172	0.00189	CcSEcCtD
Ceftriaxone—Pancreatitis—Doxorubicin—sarcoma	0.00172	0.00188	CcSEcCtD
Ceftriaxone—Hypersensitivity—Mitoxantrone—sarcoma	0.0017	0.00186	CcSEcCtD
Ceftriaxone—Vomiting—Thiotepa—sarcoma	0.0017	0.00186	CcSEcCtD
Ceftriaxone—ALB—testis—sarcoma	0.0017	0.0197	CbGeAlD
Ceftriaxone—Vomiting—Dactinomycin—sarcoma	0.00169	0.00185	CcSEcCtD
Ceftriaxone—Rash—Thiotepa—sarcoma	0.00169	0.00184	CcSEcCtD
Ceftriaxone—Dermatitis—Thiotepa—sarcoma	0.00168	0.00184	CcSEcCtD
Ceftriaxone—Headache—Thiotepa—sarcoma	0.00167	0.00183	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00167	0.00183	CcSEcCtD
Ceftriaxone—Rash—Dactinomycin—sarcoma	0.00167	0.00183	CcSEcCtD
Ceftriaxone—Renal failure—Epirubicin—sarcoma	0.00166	0.00182	CcSEcCtD
Ceftriaxone—Stomatitis—Epirubicin—sarcoma	0.00164	0.0018	CcSEcCtD
Ceftriaxone—Jaundice—Epirubicin—sarcoma	0.00164	0.0018	CcSEcCtD
Ceftriaxone—Pain—Etoposide—sarcoma	0.00164	0.0018	CcSEcCtD
Ceftriaxone—Neutropenia—Doxorubicin—sarcoma	0.00164	0.00179	CcSEcCtD
Ceftriaxone—Diarrhoea—Vincristine—sarcoma	0.00162	0.00177	CcSEcCtD
Ceftriaxone—Haematuria—Epirubicin—sarcoma	0.00161	0.00176	CcSEcCtD
Ceftriaxone—ALB—liver—sarcoma	0.0016	0.0186	CbGeAlD
Ceftriaxone—Epistaxis—Epirubicin—sarcoma	0.00159	0.00174	CcSEcCtD
Ceftriaxone—Nausea—Thiotepa—sarcoma	0.00159	0.00174	CcSEcCtD
Ceftriaxone—Feeling abnormal—Etoposide—sarcoma	0.00158	0.00173	CcSEcCtD
Ceftriaxone—Diarrhoea—Mitoxantrone—sarcoma	0.00158	0.00173	CcSEcCtD
Ceftriaxone—Nausea—Dactinomycin—sarcoma	0.00158	0.00172	CcSEcCtD
Ceftriaxone—Agranulocytosis—Epirubicin—sarcoma	0.00157	0.00172	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Etoposide—sarcoma	0.00157	0.00172	CcSEcCtD
Ceftriaxone—Dizziness—Vincristine—sarcoma	0.00157	0.00172	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00155	0.00169	CcSEcCtD
Ceftriaxone—Renal failure—Doxorubicin—sarcoma	0.00153	0.00168	CcSEcCtD
Ceftriaxone—Urticaria—Etoposide—sarcoma	0.00153	0.00167	CcSEcCtD
Ceftriaxone—Haemoglobin—Epirubicin—sarcoma	0.00152	0.00167	CcSEcCtD
Ceftriaxone—Jaundice—Doxorubicin—sarcoma	0.00152	0.00167	CcSEcCtD
Ceftriaxone—Stomatitis—Doxorubicin—sarcoma	0.00152	0.00167	CcSEcCtD
Ceftriaxone—Abdominal pain—Etoposide—sarcoma	0.00152	0.00166	CcSEcCtD
Ceftriaxone—Body temperature increased—Etoposide—sarcoma	0.00152	0.00166	CcSEcCtD
Ceftriaxone—Haemorrhage—Epirubicin—sarcoma	0.00151	0.00166	CcSEcCtD
Ceftriaxone—Vomiting—Vincristine—sarcoma	0.00151	0.00165	CcSEcCtD
Ceftriaxone—Rash—Vincristine—sarcoma	0.00149	0.00164	CcSEcCtD
Ceftriaxone—Dermatitis—Vincristine—sarcoma	0.00149	0.00163	CcSEcCtD
Ceftriaxone—Haematuria—Doxorubicin—sarcoma	0.00149	0.00163	CcSEcCtD
Ceftriaxone—Headache—Vincristine—sarcoma	0.00148	0.00162	CcSEcCtD
Ceftriaxone—Epistaxis—Doxorubicin—sarcoma	0.00147	0.00161	CcSEcCtD
Ceftriaxone—Vomiting—Mitoxantrone—sarcoma	0.00147	0.00161	CcSEcCtD
Ceftriaxone—Agranulocytosis—Doxorubicin—sarcoma	0.00146	0.00159	CcSEcCtD
Ceftriaxone—Rash—Mitoxantrone—sarcoma	0.00146	0.00159	CcSEcCtD
Ceftriaxone—Dermatitis—Mitoxantrone—sarcoma	0.00145	0.00159	CcSEcCtD
Ceftriaxone—Headache—Mitoxantrone—sarcoma	0.00145	0.00158	CcSEcCtD
Ceftriaxone—Erythema multiforme—Epirubicin—sarcoma	0.00143	0.00157	CcSEcCtD
Ceftriaxone—SLC15A2—testis—sarcoma	0.00142	0.0164	CbGeAlD
Ceftriaxone—Hypersensitivity—Etoposide—sarcoma	0.00141	0.00155	CcSEcCtD
Ceftriaxone—Haemoglobin—Doxorubicin—sarcoma	0.00141	0.00154	CcSEcCtD
Ceftriaxone—Nausea—Vincristine—sarcoma	0.00141	0.00154	CcSEcCtD
Ceftriaxone—Flushing—Epirubicin—sarcoma	0.00141	0.00154	CcSEcCtD
Ceftriaxone—Haemorrhage—Doxorubicin—sarcoma	0.0014	0.00153	CcSEcCtD
Ceftriaxone—Nausea—Mitoxantrone—sarcoma	0.00137	0.0015	CcSEcCtD
Ceftriaxone—Chills—Epirubicin—sarcoma	0.00136	0.00149	CcSEcCtD
Ceftriaxone—Pruritus—Etoposide—sarcoma	0.00136	0.00149	CcSEcCtD
Ceftriaxone—Erythema multiforme—Doxorubicin—sarcoma	0.00133	0.00145	CcSEcCtD
Ceftriaxone—Diarrhoea—Etoposide—sarcoma	0.00131	0.00144	CcSEcCtD
Ceftriaxone—Flushing—Doxorubicin—sarcoma	0.0013	0.00142	CcSEcCtD
Ceftriaxone—Flatulence—Epirubicin—sarcoma	0.0013	0.00142	CcSEcCtD
Ceftriaxone—Dysgeusia—Epirubicin—sarcoma	0.00129	0.00141	CcSEcCtD
Ceftriaxone—Dizziness—Etoposide—sarcoma	0.00127	0.00139	CcSEcCtD
Ceftriaxone—Chills—Doxorubicin—sarcoma	0.00126	0.00138	CcSEcCtD
Ceftriaxone—ALB—lymph node—sarcoma	0.00123	0.0143	CbGeAlD
Ceftriaxone—Ill-defined disorder—Epirubicin—sarcoma	0.00122	0.00134	CcSEcCtD
Ceftriaxone—Vomiting—Etoposide—sarcoma	0.00122	0.00134	CcSEcCtD
Ceftriaxone—Anaemia—Epirubicin—sarcoma	0.00122	0.00133	CcSEcCtD
Ceftriaxone—Agitation—Epirubicin—sarcoma	0.00121	0.00133	CcSEcCtD
Ceftriaxone—Rash—Etoposide—sarcoma	0.00121	0.00132	CcSEcCtD
Ceftriaxone—Dermatitis—Etoposide—sarcoma	0.00121	0.00132	CcSEcCtD
Ceftriaxone—Headache—Etoposide—sarcoma	0.0012	0.00132	CcSEcCtD
Ceftriaxone—Flatulence—Doxorubicin—sarcoma	0.0012	0.00132	CcSEcCtD
Ceftriaxone—Dysgeusia—Doxorubicin—sarcoma	0.00119	0.00131	CcSEcCtD
Ceftriaxone—Malaise—Epirubicin—sarcoma	0.00119	0.0013	CcSEcCtD
Ceftriaxone—Leukopenia—Epirubicin—sarcoma	0.00118	0.00129	CcSEcCtD
Ceftriaxone—Palpitations—Epirubicin—sarcoma	0.00117	0.00128	CcSEcCtD
Ceftriaxone—Convulsion—Epirubicin—sarcoma	0.00114	0.00125	CcSEcCtD
Ceftriaxone—Nausea—Etoposide—sarcoma	0.00114	0.00125	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Doxorubicin—sarcoma	0.00113	0.00124	CcSEcCtD
Ceftriaxone—Anaemia—Doxorubicin—sarcoma	0.00113	0.00123	CcSEcCtD
Ceftriaxone—Agitation—Doxorubicin—sarcoma	0.00112	0.00123	CcSEcCtD
Ceftriaxone—Discomfort—Epirubicin—sarcoma	0.00111	0.00121	CcSEcCtD
Ceftriaxone—Malaise—Doxorubicin—sarcoma	0.0011	0.0012	CcSEcCtD
Ceftriaxone—Leukopenia—Doxorubicin—sarcoma	0.00109	0.0012	CcSEcCtD
Ceftriaxone—Palpitations—Doxorubicin—sarcoma	0.00108	0.00118	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Epirubicin—sarcoma	0.00108	0.00118	CcSEcCtD
Ceftriaxone—Oedema—Epirubicin—sarcoma	0.00108	0.00118	CcSEcCtD
Ceftriaxone—Infection—Epirubicin—sarcoma	0.00107	0.00117	CcSEcCtD
Ceftriaxone—Convulsion—Doxorubicin—sarcoma	0.00106	0.00116	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Epirubicin—sarcoma	0.00105	0.00115	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Epirubicin—sarcoma	0.00104	0.00114	CcSEcCtD
Ceftriaxone—SLC15A2—lymph node—sarcoma	0.00103	0.0119	CbGeAlD
Ceftriaxone—Discomfort—Doxorubicin—sarcoma	0.00103	0.00112	CcSEcCtD
Ceftriaxone—Oedema—Doxorubicin—sarcoma	0.000996	0.00109	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Doxorubicin—sarcoma	0.000996	0.00109	CcSEcCtD
Ceftriaxone—Infection—Doxorubicin—sarcoma	0.000989	0.00108	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Doxorubicin—sarcoma	0.000975	0.00107	CcSEcCtD
Ceftriaxone—Paraesthesia—Epirubicin—sarcoma	0.000966	0.00106	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Doxorubicin—sarcoma	0.000963	0.00105	CcSEcCtD
Ceftriaxone—Dyspepsia—Epirubicin—sarcoma	0.000947	0.00104	CcSEcCtD
Ceftriaxone—Pain—Epirubicin—sarcoma	0.00092	0.00101	CcSEcCtD
Ceftriaxone—Paraesthesia—Doxorubicin—sarcoma	0.000894	0.000979	CcSEcCtD
Ceftriaxone—Feeling abnormal—Epirubicin—sarcoma	0.000887	0.000971	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Epirubicin—sarcoma	0.00088	0.000963	CcSEcCtD
Ceftriaxone—Dyspepsia—Doxorubicin—sarcoma	0.000877	0.000959	CcSEcCtD
Ceftriaxone—Urticaria—Epirubicin—sarcoma	0.000855	0.000936	CcSEcCtD
Ceftriaxone—Pain—Doxorubicin—sarcoma	0.000852	0.000932	CcSEcCtD
Ceftriaxone—Abdominal pain—Epirubicin—sarcoma	0.000851	0.000931	CcSEcCtD
Ceftriaxone—Body temperature increased—Epirubicin—sarcoma	0.000851	0.000931	CcSEcCtD
Ceftriaxone—Feeling abnormal—Doxorubicin—sarcoma	0.000821	0.000898	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000814	0.000891	CcSEcCtD
Ceftriaxone—Hypersensitivity—Epirubicin—sarcoma	0.000793	0.000868	CcSEcCtD
Ceftriaxone—Urticaria—Doxorubicin—sarcoma	0.000791	0.000866	CcSEcCtD
Ceftriaxone—Body temperature increased—Doxorubicin—sarcoma	0.000787	0.000862	CcSEcCtD
Ceftriaxone—Abdominal pain—Doxorubicin—sarcoma	0.000787	0.000862	CcSEcCtD
Ceftriaxone—Pruritus—Epirubicin—sarcoma	0.000761	0.000833	CcSEcCtD
Ceftriaxone—Diarrhoea—Epirubicin—sarcoma	0.000736	0.000806	CcSEcCtD
Ceftriaxone—Hypersensitivity—Doxorubicin—sarcoma	0.000734	0.000803	CcSEcCtD
Ceftriaxone—Dizziness—Epirubicin—sarcoma	0.000712	0.000779	CcSEcCtD
Ceftriaxone—Pruritus—Doxorubicin—sarcoma	0.000705	0.000771	CcSEcCtD
Ceftriaxone—Vomiting—Epirubicin—sarcoma	0.000684	0.000749	CcSEcCtD
Ceftriaxone—Diarrhoea—Doxorubicin—sarcoma	0.000681	0.000746	CcSEcCtD
Ceftriaxone—Rash—Epirubicin—sarcoma	0.000679	0.000743	CcSEcCtD
Ceftriaxone—Dermatitis—Epirubicin—sarcoma	0.000678	0.000742	CcSEcCtD
Ceftriaxone—Headache—Epirubicin—sarcoma	0.000674	0.000738	CcSEcCtD
Ceftriaxone—Dizziness—Doxorubicin—sarcoma	0.000659	0.000721	CcSEcCtD
Ceftriaxone—Nausea—Epirubicin—sarcoma	0.000639	0.0007	CcSEcCtD
Ceftriaxone—Vomiting—Doxorubicin—sarcoma	0.000633	0.000693	CcSEcCtD
Ceftriaxone—Rash—Doxorubicin—sarcoma	0.000628	0.000687	CcSEcCtD
Ceftriaxone—Dermatitis—Doxorubicin—sarcoma	0.000627	0.000687	CcSEcCtD
Ceftriaxone—Headache—Doxorubicin—sarcoma	0.000624	0.000683	CcSEcCtD
Ceftriaxone—Nausea—Doxorubicin—sarcoma	0.000592	0.000647	CcSEcCtD
